Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Robbins LLP is Investigating Allegations that Atara Biotherapeutics, Inc. (ATRA) Misled Investors Regarding its Drug Candidate
-
Robbins LLP is Investigating Allegations that Power Solutions International, Inc. (PSIX) Misled Investors Regarding its Business Prospects
-
Robbins LLP is Investigating Allegations that Hercules Capital, Inc. (HTGC) Misled Investors Regarding its Due Diligence in Deal Sourcing, Loan Originating
-
Robbins LLP is Investigating Allegations that Lufax Holding Ltd. (LU) had Inadequate Internal Controls
-
Robbins LLP is Investigating Allegations that Coty Inc. (COTY) Misled Investors Regarding its Financial Performance
-
Robbins LLP is Investigating Allegations that Concorde International Group, Ltd. (CIGL) was the Subject of a Pump-and-Dump Promotion Scheme
-
Robbins LLP is Investigating Allegations that Boston Scientific Corporation (BSX) Misled Investors Regarding Projected Revenue
-
Robbins LLP is Investigating Allegations that Aquestive Therapeutics, Inc. (AQST) Misled Investors Regarding Approval of Anaphylm
-
Robbins LLP is Investigating Allegations that Driven Brands Holdings Inc. (DRVN) Made Material Errors in its Previously Issued Consolidated Financial State
-
Robbins LLP is Investigating Allegations that Nektar Therapeutics (NKTR) Overstated the Prospects of its REZOLVE-AA Trial